David R. Koos, PhD, DBA – Chairman & CEO

David Koos is the Founder, Chairman & CEO of Entest BioMedical Inc.   Dr. Koos has over 26 years of investment banking and venture capital experience with a primary focus on fully reporting medical and biotechnology ventures.  He holds a Ph.D. degree in Sociology and a Doctor of Business Administration in Finance.  Additionally, he has authored / co-authored several peer reviewed journal articles primarily on biotechnology related subjects.

Feng Lin, MD, PhD – Director of Research

Dr. Feng Lin has a strong background in cell biology, cancer biology and therapy. He also has extensive experience with tissue imaging, and stem cell differentiation. Previously, Dr. Lin was a Senior Research Scientist, Research & Development with Inovio BC, San Diego and Postdoctoral Fellow in the Burnham Institute for Medical Research, La Jolla. He received his M.D. from Central South University Xiangya School of Medicine, Changsha, China, along with a M.S. Biochemistry & Molecular Biology and a Ph.D. Hematology & Physiology from the same institution. Dr. Lin's research work has been widely published in international scientific journals.